Endothelial barrier antigen-immunoreactivity is conversely associated with blood-brain barrier dysfunction after embolic stroke in rats

European Journal of Histochemistry

Volumn 57, Issue 4, 2013, Pages 255-261

  Pelz, J ^a   Hartig W ^a   Weise, C ^a   Hobohm, C ^a   Schneider, D ^a   Krueger, M ^a   Kacza, J ^a   Michalski, D ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Blood brain barrier; EBA; Embolic model; Ischemic stroke; Matrix metalloproteinase

Indexed keywords

DIAGNOSTIC AGENT; DRUG DERIVATIVE; ENDOTHELIAL BARRIER ANTIGEN, RAT; FITC ALBUMIN; FITC-ALBUMIN; FLUORESCEIN ISOTHIOCYANATE; MEMBRANE ANTIGEN; SERUM ALBUMIN;

ANIMAL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; IMMUNOLOGY; MALE; PHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; ANTIGENS, SURFACE; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; FLUORESCEIN-5-ISOTHIOCYANATE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; RATS; RATS, WISTAR; SERUM ALBUMIN; STROKE;

EID: 84890940486     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/ejh.2013.e38     Document Type: Article

References (38)

1. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1,026 experimental treatments in acute stroke. Ann Neurol 2006;59:467-477.
2. Del Zoppo GJ. Virchow's triad: the vascular basis of cerebral injury. Rev Neurol Dis 2008;5(Suppl. 1):12-21.
3. Del Zoppo GJ. The neurovascular unit in the setting of stroke. J Intern Med 2010; 267:156-161.
4. Del Zoppo GJ, Hallenbeck JM. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 2000;98:73-81.
5. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview. Structure, regulation, and clinical implications. Neurobiol Dis 2004;16:1-13.
6. Bechmann I, Galea I, Perry VH. What is the blood-brain barrier (not)? Trends Immunol 2007;28:5-11.
7. Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci 2007;10:1369-1376.
8. Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 2008;32:200-219.
9. Nishigaya K, Yagi S, Sato T, Kanemaru K, Nukui H. Impairment and restoration of the endothelial blood-brain barrier in the rat cerebral infarction model assessed by expression of endothelial barrier antigen immunoreactivity. Acta Neuropathol 2000; 99:231-237.
10. Lin B, Ginsberg MD. Quantitative assessment of the normal cerebral microvascula-ture by endothelial barrier antigen (EBA) immunohistochemistry:application to focal cerebral ischemia. Brain Res 2000; 865:237-244.
11. Lu A, Clark J F, Broderick J P, Pyne-Geithman GJ, Wagner KR, Ran R, et al. Reperfusion activates metalloproteinases that contribute to neurovascular injury. Exp Neurol 2008;210:549-559.
12. Suofu Y, Clark J, Broderick J, Wagner KR, Tomsick T, Sa Y, et al. Peroxynitrite decomposition catalyst prevents matrix metallo-proteinase activation and neurovascular injury after prolonged cerebral ischemia in rats. J Neurochem 2010;115:1266-1276.
13. Katsu M, Niizuma K, Yoshioka H, Okami N, Sakata H, Chan PH. Hemoglobin-induced oxidative stress contributes to matrix metalloproteinase activation and blood-brain barrier dysfunction in vivo. J Cereb Blood Flow Metab 2010;30:1939-1950.
14. Sternberger NH, Sternberger LA, Kies MW, Shear CR. Cell surface endothelial proteins altered in experimental allergic encephalomyelitis. J Neuroimmunol 1989; 21:241-248.
15. Lin B, Ginsberg MD, Zhao W, Alonso OF, Belayev L, Busto R. Quantitative analysis of microvascular alterations in traumatic brain injury by endothelial barrier antigen immunohistochemistry. J Neurotrauma 2001;18:389-397.
16. Perdiki M, Farooque M, Holtz A, Li GL, Olsson Y. Expression of endothelial barrier antigen immunoreactivity in blood vessels following compression trauma to rat spinal cord. Temporal evolution and relation to the degree of the impact. Acta Neuropathol 1998;96:8-12.
17. Sternberger NH, Sternberger LA. Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci USA 1987;84:8169-8173.
18. Ghabriel MN, Lu JJ, Hermanis G, Zhu C, Setchell B P. Expression of a blood-brain barrier-specific antigen in the reproductive tract of the male rat. Reproduction 2002;123:389-397.
19. Cassella J P, Lawrenson JG, Lawrence L, Firth JA. Differential distribution of an endothelial barrier antigen between the pial and cortical microvessels of the rat. Brain Res 1997;744:335-338.
20. Saubaméa B, Cochois-Guégan V, Cisternino S, Scherrmann J. Heterogeneity in the rat brain vasculature revealed by quantitative confocal analysis of endothelial barrier antigen and P-glyco-protein expression. J Cereb Blood Flow Metab 2012;32:81-92.
21. Krum JM, Kenyon KL, Rosenstein JM. Expression of blood-brain barrier characteristics following neuronal loss and astroglial damage after administration of anti-Thy-1 immunotoxin. Exp Neurol 1997;146:33-45.
22. Zhu C, Ghabriel M, Blumbergs P, Reilly P, Manavis J, Youssef J, et al. Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood-brain barrier (BBB). Exp Neurol 2001;169:72-82.
23. Candelario-Jalil E, Yang Y, Rosenberg GA. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinas-es in neuroinflammation and cerebral ischemia. Neuroscience 2008;158:983-994.
24. Michalski D, Grosche J, Pelz J, Schneider D, Weise C, Bauer U, et al. A novel quantification of blood-brain barrier damage and histochemical typing after embolic stroke in rats. Brain Res 2010;1359:186-200.
25. Zhang Z, Zhang RL, Jiang Q, Raman SB, Cantwell L, Chopp M. A new rat model of thrombotic focal cerebral ischemia. J Cereb Blood Flow Metab 1997;17:123-135.
26. Bräuninger S, Kleinschnitz C. Rodent models of focal cerebral ischemia:proce-dural pitfalls and translational problems. Exp Transl Stroke Med 2009;1:8.
27. Michalski D, Pelz J, Weise C, Kacza J, Boltze J, Grosche J, et al. Early outcome and blood-brain barrier integrity after co-administered thrombolysis and hyperbaric oxygenation in experimental stroke. Exp Transl Stroke Med 2011;3:5.
28. Bhattacharjee AK, Kondoh T, Ikeda M, Kohmura E. MMP-9 and EBA immunoreac-tivity after papaverine mediated opening of the blood-brain barrier. Neuroreport 2002;13:2217-2221.
29. Ghabriel MN, Lu JJ, Tadros R, Hermanis G. A narrow time-window for access to the brain by exogenous protein after immuno-logical targeting of a blood-brain barrier antigen. J Comp Pathol 2004;131:52-60.
30. Ghabriel MN, Zhu C, Hermanis G, Allt G. Immunological targeting of the endothe-lial barrier antigen (EBA) in vivo leads to opening of the blood-brain barrier. Brain Res 2000;878:127-135.
31. Ghabriel MN, Zhu C, Leigh C. Electron microscope study of blood-brain barrier opening induced by immunological targeting of the endothelial barrier antigen. Brain Res 2002;934:140-151.
32. Strbian D, Durukan A, Pitkonen M, Marinkovic I, Tatlisumak E, Pedrono E. The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 2008;153:175-181.
33. Durukan A, Marinkovic I, Strbian D, Pitkonen M, Pedrono E, Soinne L. Post-ischemic blood-brain barrier leakage in rats:One-week follow-up by MRI. Brain Res 2009;1280:158-165.
34. Preston E, Sutherland G, Finsten A. Three openings of the blood-brain barrier produced by forebrain ischemia in the rat. Neurosci Lett 1993;149:75-78.
35. Belayev L, Busto R, Zhao W, Ginsberg MD. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 1996;739:88-96.
36. Pillai DR, Dittmar MS, Baldaranov D, Heidemann RM, Henning EC, Schuierer G, et al. Cerebral ischemia-reperfusion injury in rats - A 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation. J Cereb Blood Flow Metab 2009;29:1846-1855.
37. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998;29:2189-2195.
38. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 2007;27:697-709.